Work

Cardiotoxicity due to cancer therapy.

Year: 2011

Type: article

Abstract: The convergence of novel molecular techniques for the study of cardiovascular disease—together with the development of an armamentarium of molecular-targeted anticancer therapies—is fueling the interest of molecular cardiologists in probing the mechanisms of cancer-therapy–induced cardiac toxicity. Such studies have the potential to develop strategies that will prevent cardiac toxicity from becoming a barrier to effective anticancer therapy. They might also provide novel insights into the pathogenesis of non-cancer-therapy–induced human heart disease.

Source: PubMed

Authors: Aarif Y Khakoo, Peter P Liu, Thomas Force, Gabriel Lopez-Berestein, Lee W Jones, Jay Schneider, Joseph Hill

Institutions: The University of Texas MD Anderson Cancer Center, University of Toronto, Thomas Jefferson University, Duke University

Language: English

Topic: Chemotherapy-induced cardiotoxicity and mitigation

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W2165832023

FWCI: 1.433

Cites: 9

Cited by: 30

Related to: 20